$RMSL

RemSleep Holdings Inc.

RemSleep develops and distributes sleep apnea products, with a focus on its DeltaWave CPAP interface, a nasal-pillows mask for delivering CPAP therapy and other respiratory needs. The company also states that it aims to develop sleep products for obstructive sleep apnea. Its target customers include durable medical equipment providers, hospitals and acute care facilities, sleep labs, physicians, and medical associations. RemSleep expects most of its revenue to come through durable medical equipment providers and hospitals, and describes marketing to these customers and online retailers. Its products are manufactured by mold makers, and it has molds made in China. RemSleep is headquartered in Clearwater, Florida. It has two employees, with other services provided by independent contractors.

0
0
1

No SEC Form 4 filings for $RMSL in the last 30 days.

See all $RMSL insider activity →
Low

REMSleep 3Q 2026: Revenue $0, EPS ($0) — 10-Q Summary

REMSleep reported no revenue in 3Q 2026, down from $7,454 a year earlier, as its retail location closed and e-commerce sales had not started. Net loss narrowed to $50,900 from $2.31M due to lower operating expenses. Management expressed doubt about the company's ability to continue as a going concern.

RMSL sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning RMSL (RemSleep Holdings Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

What's driving RMSL

AlphAI scores every news story that mentions RMSL with an AI model for sentiment and relevance, and aggregates insider trades from RemSleep Holdings Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RMSL

Score

REMSleep 3Q 2026: Revenue $0, EPS ($0) — 10-Q Summary

REMSleep reported no revenue in 3Q 2026, down from $7,454 a year earlier, as its retail location closed and e-commerce sales had not started. Net loss narrowed to $50,900 from $2.31M due to lower operating expenses. Management expressed doubt about the company's ability to continue as a going concern.

Related tickers